Zurich Cantonal Bank
BNGO icon

Zurich Cantonal Bank’s Bionano Genomics BNGO Stock Holding History

Zurich Cantonal Bank’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Hold
0
– -$23 – 2653
2024
Q1 		– Hold
0
– – – 2697
2023
Q4 		– Sell
-54
Closed -$5.64K – 2716
2023
Q3 		$9.78K Sell
54
-4
-7% -$1.05K ﹤0.01% 2741
2023
Q2 		$21.3K Sell
58
-64
-52% -$28.9K ﹤0.01% 2715
2023
Q1 		$81.2K Hold
122
– – ﹤0.01% 2399
2022
Q4 		$107K Buy
122
+11
+10% +$13.8K ﹤0.01% 2228
2022
Q3 		$122K Sell
111
-2
-2% -$2.64K ﹤0.01% 2067
2022
Q2 		$93K Sell
113
-5
-4% -$5.14K ﹤0.01% 2295
2022
Q1 		$183K Sell
118
-4
-3% -$5.4K ﹤0.01% 1944
2021
Q4 		$218K Buy
122
+1
+0.8% +$2.67K ﹤0.01% 2009
2021
Q3 		$399K Sell
121
-2
-2% -$7K ﹤0.01% 1450
2021
Q2 		$539K Buy
123
+56
+84% +$221K ﹤0.01% 1190
2021
Q1 		$327K Buy
+67
New +$378K ﹤0.01% 1492

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Zurich Cantonal Bank's BNGO Position: Q2 2024 in Review

Zurich Cantonal Bank held its Bionano Genomics (BNGO) position steady in Q2 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2653.

Zurich Cantonal Bank first reported a position in BNGO in Q1 2021 and has held it in 11 quarters since. The position peaked at $539K in Q2 2021. 53 funds tracked by Wall St. Rank hold BNGO as of Q2 2024.

  • Zurich Cantonal Bank held 0 shares of Bionano Genomics worth $0 as of Q2 2024.
  • Zurich Cantonal Bank left its Bionano Genomics share count unchanged in Q2 2024.
  • Bionano Genomics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2024, its #2653 holding.
  • Zurich Cantonal Bank first reported a position in Bionano Genomics in Q1 2021 and has held it in 11 quarters since.
  • Zurich Cantonal Bank's Bionano Genomics position peaked at $539K in Q2 2021.
  • 53 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2024.

Based on Zurich Cantonal Bank's 13F filing for Q2 2024, filed 29 Jul 2024.